Stopping cancer metabolic adaptation

At AtG, we develop new drugs and biomarkers to prevent cancer metabolic adaptation

Our mission

Advance our portfolio of therapies to clinical trials and improve the lives of those affected by advanced cancer.

Our approach

Novel mechanism of action

Innovative anti-cancer therapeutic target

Drug candidate

New small molecule candidates

New biomarker

Patient selection technology

Interested in becoming a partner?